Search results for: Multi-Indication Medicines
Filter search results
Around the World in HTAs: Canada – Autonomous yet Collaborative
9 April 2025
…consistency between systems. Each system may interpret ‘medically necessary’ according to their needs and priorities, resulting in some variability between systems. Notably, prescription and over-the counter medicines are not covered…
NICE’s new cost-effectiveness threshold: Significance, consequences, and unanswered questions
25 February 2026
…£25,000-£35,000 per QALY will result in three to five more medicines recommended each year. At the heart of the matter is a structural challenge: NICE guides decisions about which medicines…
Around The World in HTAs: France – Three Core HTA Values
12 March 2026
…services such as certain medicines and medical devices, subject to out-of-pocket payments and/or supplementary insurance. As a country that spends a significant proportion of its national income on healthcare (around 12% of…
Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB
24 March 2022
…on Health. Available from https://www.ohe.org/publications/tuberculosis. Kettler, H. and Towse, A. (2002) Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty. OHE Monograph. Available from https://www.ohe.org/publications/public-private-partnerships-research-and-development-medicines-and-vaccines-diseases…
The Cost of Drug Shortages
16 September 2024
Share this: Download publication Matthew Napier Mikel Berdud Amanda Cole Across the globe, drug shortages are becoming increasingly common. Key takeaways Drug shortages are a growing global concern, affecting multiple…
A Prescription for Green Healthcare Delivery: Insights from an Expert Sustainability Webinar
19 July 2023
…Wendy Rayner Another significant initiative is the National Green Theatre Program (NGTP). The impetus of this program is taken from NHS Highlands, which employed a multidisciplinary approach to implementing 11 projects, …
Spotlight on OHE: Recent Awards, Publications and Presentations
12 September 2012
…members that appeared over the summer include the following. Mestre-Ferrandiz, J. (2012) Opinion: ¿Son útiles las proyecciones del gasto farmacéutico? [Is projecting the medicines bill useful?] ElGlobal.net. 27 July. Available at https://bit.ly/TH97UF. Shah,…
‘HispaNICE’: the Creation of an ‘Independent Authority for the Evaluation of Health Practices and Policies’ Gathers Momentum
24 February 2021
…their technologies, drugs and therapeutic indications, prevention and public health interventions, and other health policies, balancing health results with the costs they entail for the SNHS and for society as…
CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation
14 September 2021
…health, when clearly scientific advances are affecting both the number and distribution of the types of new medicines across disease areas. Some NMEs that the CBO estimate will be lost…